50,223 results match your criteria Angina Pectoris


Smoking Behaviors in Survivors of Smoking-Related and Non-Smoking-Related Cancers.

JAMA Netw Open 2020 Jul 1;3(7):e209072. Epub 2020 Jul 1.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.

Importance: The population of cancer survivors is rapidly growing in the US. Tobacco smoking is associated with many cancers; however, whether cigarette smoking behaviors among cancer survivors vary according to cancer type-that is, smoking-related cancers (SRCs) vs non-smoking-related cancers (NSRCs)-remains unclear.

Objectives: To examine cigarette smoking prevalence and behaviors (ie, continuing or quitting smoking) among cancer survivors and to compare them between survivors of SRCs and NSRCs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2020.9072DOI Listing

Different vasoreactivity of arterial bypass grafts versus native coronary arteries in response to acetylcholine.

Clin Res Cardiol 2020 Jul 1. Epub 2020 Jul 1.

Department of Cardiology, Robert-Bosch-Krankenhaus, Auerbachstr. 110, 70376, Stuttgart, Germany.

Background: Coronary angiography is often performed in patients with recurrent angina after successful coronary artery bypass grafting (CABG) in search of the progression of atherosclerosis. However, in many of these patients, no relevant stenosis can be detected. We speculate that coronary spasm may be associated with angina in these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-020-01694-xDOI Listing

Coronary Cameral Fistula - A Rare Cause of Angina Pectoris in a Young Patient.

J Assoc Physicians India 2020 Jun;68(6):64-65

Resident, King George Medical University, Lucknow, Uttar Pradesh.

Coronary cameral fistula, a rare cause of angina pectoris in a young patient is of rare occurrence and is very sparsely reported. We present here a case of a 23 year old male with complaints of chest discomfort and breathlessness on exertion for 4 months. 2D Transthoracic echocardiography showed coronary cameral fistula opening into right atrium. Read More

View Article

Download full-text PDF

Source

Neutrophil gelatinase-associated lipocalin is a predictor of complications in the early phase of ST-elevation myocardial infarction.

Med Glas (Zenica) 2020 Aug 1;17(2). Epub 2020 Aug 1.

Urology Clinic, Clinical Centre of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Aim To evaluate a correlation of serum level of neutrophil gelatinase-associated lipocalin (NGAL) to the risk of the occurrence of complications in patients with the early phase of ST-segment elevation myocardical infarction (STEMI) treated with fibrinolytic therapy prior to percutaneous coronary intervention (PCI). Methods A total of 54 patients with the diagnosis of STEMI treated with fibrinolytic therapy (alteplase) prior to PCI were included. Patients were admitted to the Intensive Care Unit (ICU) of Clinic for Heart, Blood Vessel and Rheumatic Diseases in the period January to March 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17392/1139-20DOI Listing

[Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention].

Ter Arkh 2019 Sep 15;91(9):38-46. Epub 2019 Sep 15.

National Medical Research Center for Cardiology.

Aim: To evaluate efficacy and safety of reduced dose of direct oral anticoagulants (DOACs) as part of triple antithrombotic therapy in AF patients, undergoing elective percutaneous coronary intervention (PCI), and to identify factors, associated with this strategy.

Materials And Methods: The study is a cohort analysis of AF patients with AF, who successfully underwent elective PCI and assigned DOACs as part of triple antithrombotic therapy (TAT).Influence of a reduced DOACs dose as a part of TAT on the frequency of thecomposite efficacy endpoint (acute coronary syndrome, ischemic stroke, venous thromboembolic events, cardiovascular death and angina pectoris aggravation/need for unplanned PCI) and safety endpoint (hemorrhagic complications BARC types 2-5) were assessed using the Log-Rank criterion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/00403660.2019.09.000297DOI Listing
September 2019

[The possibilities of using levosimendan in medical preparation to Coronary Artery Bypass Grafting in coronary artery disease patients with low left ventricular ejection fraction].

Ter Arkh 2020 Jan 15;92(1):43-48. Epub 2020 Jan 15.

A.L. Myasnikov Institute of Cardiology of National Medical Research Center of Cardiology.

Aim: to work out an approach of preoperative drug preparation for CAD patients with low LVEF and varying degrees of compensation for CHF, to study the possibility of using levosimendan (L) in this preparation.

Materials And Methods: We studied 82 patients with severe angina pectoris, multivascular coronary disease, extensive postinfarction zone, LVEF ≤35%, chronic heart failure and proven viable myocardium, which performed CABG. All patients received long - term standard CHF therapy before surgery: loop diuretic, ACE/ARA, beta - blocker, aldosterone antagonist. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/00403660.2020.01.000492DOI Listing
January 2020

[Role of preoperative cardiology consultation in patients undergoing cancer surgery].

Ter Arkh 2020 Jan 15;92(1):25-29. Epub 2020 Jan 15.

Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Disease".

Aim: To evaluate the effects of preoperative cardiology consultation on the risk of perioperative cardiac complications in patients undergoing cancer surgery.

Materials And Methods: 74 patients with bronchial, lung, mediastinal and gastrointestinal cancer were referred to the cardiologist as a part of the preoperative management. Patients were assigned either to Group 1 (n=21), who required non - invasive testing or invasive coronary angiography (CAG), or to Group 2 (n=53), who did not have any indications to additional testing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/00403660.2020.01.000478DOI Listing
January 2020

[Prinzmetal angina. Questions of pathogenesis, clinic, diagnosis and treatment].

Ter Arkh 2019 Nov 15;91(11):116-123. Epub 2019 Nov 15.

Vishnevsky 3 Central Military Clinical Hospital.

Current problems of Prinzmetal angina (vasospastic angina, variant angina) considers in this review. Attention is drawn to early diagnosis, which should be comprehensive, taking into account possible atypical courses and the development of complications. The important role of electrocardiographic monitoring (including using implantable recorders) is highlighted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26442/00403660.2019.11.000107DOI Listing
November 2019

Therapeutic Angiogenesis with Sound Waves.

Ann Vasc Dis 2020 Jun;13(2):116-125

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Along with the progress of global aging, the prognosis of severe ischemic heart disease (IHD) remains poor, and thus the development of effective angiogenic therapy remains an important clinical unmet need. We have developed low-energy extracorporeal cardiac shock wave therapy as an innovative minimally invasive angiogenic therapy and confirmed its efficacy in a porcine chronic myocardial ischemia model in animal experiments as well as in patients with refractory angina. Since ultrasound is more advantageous for clinical application than shock waves, we then aimed to develop ultrasound therapy for IHD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3400/avd.ra.20-00010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315235PMC

Serum Exosomal MicroRNA-21, MicroRNA-126, and PTEN Are Novel Biomarkers for Diagnosis of Acute Coronary Syndrome.

Front Physiol 2020 11;11:654. Epub 2020 Jun 11.

Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.

Acute coronary syndrome (ACS) is a serious threat to public health. Based on clinical manifestations, ACS can be classified into unstable angina (UA) pectoris and acute myocardial infarction (AMI). The purpose of this study was to explore the possibility of using serum exosomal microRNA (miR)-126, miR-21, and phosphatase and tensin homolog (PTEN) expression levels as biomarkers of UA and AMI and to investigate whether these levels were positively correlated with the severity of coronary stenosis based on the Gensini score. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2020.00654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300246PMC

Prospective partially randomized comparison of clopidogrel loading versus maintenance dosing to prevent periprocedural myocardial infarction after stenting for stable angina pectoris: Results from the "Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients (MECCA)" study.

Int J Clin Pharmacol Ther 2020 Jun 26. Epub 2020 Jun 26.

What Is Known And Objective: Pre-treatment of clopidogrel 600 mg is better than 300 mg loading for reducing periprocedural myocardial infarction (PMI). We aimed to evaluate pre-treatment methods for preventing PMI among patients undergoing conventional coronary angiography (CAG) for stable angina pectoris.

Materials And Methods: The study analyzed 402 patients who underwent percutaneous coronary intervention (PCI) during 2010 - 2011 at three Korean hospitals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5414/CP203644DOI Listing

[Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study].

Korean J Gastroenterol 2020 Jun;75(6):333-340

Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Background/aims: Non-cardiac chest pain (NCCP) is defined as recurrent angina pectoris-like pain without evidence of coronary heart disease, and is usually related to esophageal diseases, such as gastroesophageal reflux disease (GERD). Proton pump inhibitors (PPIs) are important for diagnosis and treatment. Many studies have been conducted on the use of PPIs in patients with GERD-related NCCP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4166/kjg.2020.75.6.333DOI Listing

Sex and Age Differences in Patients With Unstable Angina Pectoris: A Single-Center Retrospective Study.

Am J Med Sci 2020 May 20. Epub 2020 May 20.

Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Background: Sex and age may affect the pathogenesis of coronary heart disease, such as cardiovascular risk factors, treatment and prognosis, but this information is not well known.

Methods: This was a single-center retrospective cohort study. Patients with unstable angina pectoris between January 2013 and June 2018 were included and stratified into 4 age groups (<55, 55-64, 65-74 and ≥75 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjms.2020.05.020DOI Listing

Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).

Am J Cardiol 2020 May 16. Epub 2020 May 16.

The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, Ohio. Electronic address:

Ranolazine is approved for patients with chronic stable angina but has not been formally studied in patients with refractory angina pectoris (RAP). Patients with RAP have limited therapeutic options and significant limitations in their quality of life. The Ranolazine Refractory Angina Registry was designed to evaluate the safety, tolerability, and effectiveness of ranolazine in RAP patients in order to expand treatment options for this challenging patient population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2020.05.020DOI Listing

Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.

Heart Vessels 2020 Jun 12. Epub 2020 Jun 12.

Department of Medical Science and Cardiorenal Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Adiponectin (APN) has cardioprotective properties and bisoprolol has been reported to increase myocardial APN expression and reduce myocardial damage. Administration of landiolol, which has a higher cardio-selectivity and shorter half-life than bisoprolol, during the percutaneous coronary intervention (PCI) may increase serum APN and high-molecular weight (HMW)-APN, an active form of APN, in patients with stable angina pectoris (SAP). We recruited 70 patients with SAP and randomized them to intravenous landiolol during PCI (N = 35) or control group (N = 35). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00380-020-01637-6DOI Listing

Network pharmacology-based therapeutic mechanism of Kuanxiong aerosol for angina pectoris.

J Ethnopharmacol 2020 Jun 9;261:113079. Epub 2020 Jun 9.

Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China. Electronic address:

Ethnopharmacological Relevance: Kuanxiong aerosol has been reported to be an effective and safe clinical treatment for angina pectoris (AP).

Aim Of The Study: To explore the potential pharmacological mechanism of Kuanxiong aerosol by combined methods of network pharmacology prediction and experimental verification.

Materials And Methods: Networks of Kuanxiong aerosol-associated targets and AP-related genes were constructed through STRING database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2020.113079DOI Listing

[The organizational clinical system of development of medical care based on electronic personified data of medical services under angina pectoris and myocardium infarction].

Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2020 May;28(3):464-470

The Federal State Autonomous Educational Institution of Higher Education "The Peoples' Friendship University of Russia" (RUDN University), 117198, Moscow, Russia.

The article presents the analysis of quality of medical care of patients with coronary heart disease at the phases of the clinic, ambulance and hospital based on the data from electronic personalized records and registry accounts of the territorial mandatory health insurance foundation. The results of implemented analysis and application of principle of inter-agency information interaction, the clinical organizational system of managing quality of outputs of medical care provision to patients with ischemic heart disease has been developed. The developed medical care quality management system based on database of personalized electronic patient records was tested in practice and demonstrated positive results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.32687/0869-866X-2020-28-3-464-470DOI Listing

A multiple risk factor program is associated with decreased risk of cardiovascular disease in 70-year-olds: A cohort study from Sweden.

PLoS Med 2020 Jun 11;17(6):e1003135. Epub 2020 Jun 11.

Unit of Geriatric Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.

Background: In individuals below 65 years of age, primary prevention programs have not been successful in reducing the risk of cardiovascular disease (CVD) and death. However, no large study to our knowledge has previously evaluated the effects of prevention programs in individuals aged 65 years or older. The present cohort study evaluated the risk of CVD in a primary prevention program for community-dwelling 70-year-olds. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.1003135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289341PMC

The Effect of Enhanced External Counterpulsation (EECP) on Quality of life in Patient with Coronary Artery Disease not Amenable to PCI or CABG.

Cureus 2020 May 6;12(5):e7987. Epub 2020 May 6.

Cardiology, Hayatabad Medical Complex, Peshawar, PAK.

Enhanced External Counterpulsation (EECP) is a non-invasive FDA approved therapy for patients with refractory angina pectoris. The EECP mechanism of action is similar to that of an intra-aortic balloon pump (IABP) by administering a vigorous pressure pulse via external blood pressure cuffs during the diastole. The benefit of EECP includes improvement in angina severity, angina stability, maximal walking capacity and generalized improvement in overall health. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.7987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273423PMC

(Epicardial and microvascular) angina or atypical chest pain: differential diagnoses with cardiovascular magnetic resonance.

Eur Heart J Suppl 2020 Jun 29;22(Suppl E):E116-E120. Epub 2020 Mar 29.

Centro Cardiologico Monzino, IRCCS, Via C. Parea 4, 20138 Milan, Italy.

Angina pectoris is a chest discomfort caused by myocardial ischaemia, and it is classified as 'typical' or 'atypical' if specific features are present. Unfortunately, there is a heterogeneous list of cardiac diseases characterized by this symptom as onset sign. Mostly, angina is due to significant epicardial coronary artery stenosis, which causes inadequate oxygen supply increase after raised myocardial oxygen demand. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/suaa075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270897PMC

Treatment of stable ischaemic heart disease: the old and the new.

Eur Heart J Suppl 2020 Jun 29;22(Suppl E):E54-E59. Epub 2020 Mar 29.

S.C. di Cardiologia, Ospedale S. Maria della Misericordia, Perugia, Italy.

Stable ischaemic heart disease is a frequent and very heterogeneous condition. Drug therapy is important, in these patients, for improving their prognosis and controlling their symptoms. The typical clinical manifestation of obstructive coronary disease is This symptom can be improved by various classes of compounds, namely beta-blockers (BBs), calcium antagonist, and nitrates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/suaa060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270915PMC

Impact of Previous Angina on Clinical Outcomes in ST-Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.

Chonnam Med J 2020 May 25;56(2):136-143. Epub 2020 May 25.

The Heart Center and Cardiovascular Convergence Research Center of Chonnam National University Hospital, Gwangju, Korea.

The present study sought to assess the impact of previous angina symptoms on real world clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) who had undergone successful percutaneous coronary interventions using drug-eluting stents (DES). Patients were selected from 13,650 consecutive patients enrolled in the Korea Acute Myocardial Infarction-National Institute of Health (KAMIR-NIH) registry. A total of 5167 STEMI patients were divided into a previous-angina group (n=1129) and a control group (n=4038). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4068/cmj.2020.56.2.136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250664PMC

Utility of angiography-physiology coregistration maps during percutaneous coronary intervention in clinical practice.

Cardiovasc Interv Ther 2020 Jun 7. Epub 2020 Jun 7.

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

This study aimed to evaluate the utility and feasibility of physiological maps coregistered with angiograms using the pullback of a pressure guidewire with continuous instantaneous wave-free ratio (iFR) measurements. iFR pullback was obtained for 70 lesions from 70 patients with stable angina pectoris using SyncVision (Philips Corp.). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12928-020-00668-0DOI Listing

Fractional Flow Reserve and "Hard" Endpoints.

J Am Coll Cardiol 2020 Jun;75(22):2800-2803

Division of Cardiovascular Medicine and the Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.04.042DOI Listing

Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.

J Am Coll Cardiol 2020 Jun;75(22):2785-2799

Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden. Electronic address:

Background: Intracoronary pressure wire measurement of fractional flow reserve (FFR) provides decision-making guidance during percutaneous coronary intervention (PCI). However, limited data exist on the effect of FFR on long-term clinical outcomes in patients with stable angina pectoris.

Objectives: The purpose of this study was to determine the association between the usage of FFR and all-cause mortality in patients with stable angina undergoing PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.04.018DOI Listing

Clinical efficacy of ticagrelor combined with aspirin in patients with coronary heart disease angina pectoris and its effects on NT-ProBNP and CK-MB levels.

Eur Rev Med Pharmacol Sci 2020 May;24(10):5750-5757

Department of Cardiology, Huaiyin Hospital of Huai'an City, Huai'an, P.R. China.

Objective: This study aims to explore the clinical efficacy of ticagrelor combined with aspirin in patients with coronary heart disease angina pectoris and the effects on N terminal pro B type natriuretic peptide (NT-ProBNP) and creatine kinase-MB (CK-MB) levels.

Patients And Methods: A total of 150 patients with coronary heart disease angina pectoris were prospectively analyzed in this study. These patients were admitted to Huaiyin Hospital of Huai'an City from February 2017 to February 2019. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26355/eurrev_202005_21367DOI Listing

[Chemical and pharmacological progress on a Tibetan folk medicine formula Bawei Chenxiang Powder].

Zhongguo Zhong Yao Za Zhi 2020 May;45(9):2063-2072

Modern Research Center of Traditional Chinese Medicine, School of Chinese Materia Medica,Beijing University of Chinese Medicine Beijing 100029, China.

Bawei Chenxiang Powder is a traditional Tibetan folk medicine formula, consisting of resinous wood of Aquilaria sinensis, kernel of Myristica fragrans, fruit of Choerospondias axillaris, travertine, resin of Boswellia carterii or B. bhaw-dajiana, stem of Aucklandia lappa, fruit of Terminalia chebula(roasted), and flower of Gossampinus malabarica. It has the function of clearing heart heat, nourishing heart, tranquilizing mind, and inducing resuscitation, which has been used for the treatment of coronary heart disease and angina pectoris. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20200224.201DOI Listing

Exercise Electrocardiography and Computed Tomography Coronary Angiography for Patients With Suspected Stable Angina Pectoris: A Post Hoc Analysis of the Randomized SCOT-HEART Trial.

JAMA Cardiol 2020 Jun 3. Epub 2020 Jun 3.

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Importance: Recent European guidance supports a diminished role for exercise electrocardiography (ECG) in the assessment of suspected stable angina.

Objective: To evaluate the utility of exercise ECG in contemporary practice and assess the value of combined functional and anatomical testing.

Design, Setting, And Participants: This is a post hoc analysis of the Scottish Computed Tomography of the Heart (SCOT-HEART) open-label randomized clinical trial, conducted in 12 cardiology chest pain clinics across Scotland for patients with suspected angina secondary to coronary heart disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2020.1567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271417PMC

Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature.

Cureus 2020 Apr 28;12(4):e7868. Epub 2020 Apr 28.

Cardiology, Kansas City University of Medicine and Biosciences, Joplin, USA.

Postural orthostatic tachycardia syndrome (POTS) is an autonomic disorder characterized by symptoms such as palpitations, dyspnea, chest discomfort, and lightheadedness affecting various systems. The pathophysiology of POTS is not completely understood due to a variety of symptoms showing that the disease is multifactorial. There is no approved uniform management strategy for POTS and hence, no drug has been approved by the United States (US) Food and Drug Administration (FDA) for it. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.7868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255540PMC

CD4+/CD8+ ratio positively correlates with coronary plaque instability in unstable angina pectoris patients but fails to predict major adverse cardiovascular events.

Ther Adv Chronic Dis 2020 18;11:2040622320922020. Epub 2020 May 18.

Department of Cardiology, Nanjing First Hospital, No. 68 Changle Road, Nanjing, 210006, China.

Background: The association between CD4+/CD8+ ratio and coronary plaque instability in patients with unstable angina pectoris (UAP) has not been investigated. We sought to elucidate the correlation between CD4+/CD8+ ratio and plaque instability in this patient population.

Methods: We enrolled 266 UAP patients who underwent pre-intervention optical coherence tomography (OCT) examination and percutaneous coronary intervention in our center from January 2016 to January 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040622320922020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238310PMC

Intracoronary and peripheral blood levels of TNF-like Cytokine 1A (TL1A) in patients with acute coronary syndrome.

Medicine (Baltimore) 2020 May;99(22):e20305

School of Humanities and Management, Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Background: TNF-like cytokine 1A (TL1A) is a subgroup of the tumor necrosis factor superfamily that exerts pleiotropic effects on cell proliferation, inflammation, activation, and differentiation of immune cells. The purpose of the current study is to investigate the clinical significance of TL1A expression in coronary and peripheral blood of patients with acute coronary syndrome (ACS) to determine if TL1A levels can serve as an accurate prognostic indicator.

Methods: A total of 141 patients undergoing coronary angiography were divided into 4 groups: Control (n = 35), Unstable Angina (UA) (n = 35), acute non-ST segment elevation myocardial infarction (NSTEMI) (n = 37), and acute ST segment elevation myocardial infarction (STEMI) (n = 34). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000020305DOI Listing

The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images: A study protocol.

Medicine (Baltimore) 2020 May;99(21):e20099

Department of Cardiology.

Introduction: Coronary microvascular dysfunction (CMVD), highly prevalent among patients with a mental disorder (anxiety or depression), is closely related to adverse cardiac events, including hospitalization, sudden cardiac death, and myocardial infarction. Shexiang Tongxin Dropping Pills (STDP), a traditional Chinese medicine, exerts endothelial protective function by anti-inflammation, anti-oxidative stress, and promoting blood circulation. STDP protects against CMVD in previous fundamental studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000020099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249860PMC

Identification of Novel Molecular Network Expression in Acute Myocardial Infarction.

Curr Genomics 2019 Aug;20(5):340-348

Medicinal Biochemistry and Molecular Biology Department, Ain Shams University, Faculty of Medicine, Cairo, Egypt.

Background: In the current study, we aimed to analyze the hypothesis that human myocardial-specific extracellular RNAs expression could be used for acute myocardial injury(AMI) diagnosis.

Methodology: We used bioinformatics' analysis to identify RNAs linked to ubiquitin system and specific to AMI, named, (lncRNA-RP11-175K6.1), (LOC101927740), microRNA-106b-5p (miR-106b-5p) and Anaphase, promoting complex 11 (). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389202920666190820142043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235391PMC

Cumulative Exposure to Long Working Hours and Occurrence of Ischemic Heart Disease: Evidence From the CONSTANCES Cohort at Inception.

J Am Heart Assoc 2020 Jun 1;9(12):e015753. Epub 2020 Jun 1.

INSERM UMS 011 UMR-S 1168 Villejuif France.

Background Long-working hours (LWH) are a probable risk factor for ischemic heart diseases (IHD); however, no previous study has considered duration of exposure to LWH when addressing this topic. We aimed to determine the association between cumulative exposure to LWH and IHD while accounting for relevant confounders. Methods and Results In this retrospective study, we included all baseline participants from the French population-based cohort CONSTANCES. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.119.015753DOI Listing

Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome.

Atherosclerosis 2020 May 18;303:21-28. Epub 2020 May 18.

Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Background And Aims: This study aimed to elucidate whether high-density lipoprotein cholesterol (HDL-C) at 3-month follow-up for patients receiving contemporary lipid-lowering therapy after acute coronary syndrome (ACS) could predict cardiac events.

Methods: The HIJ-PROPER study was a multicenter, prospective, randomized trial comparing intensive lipid-lowering therapy (pitavastatin + ezetimibe) and conventional lipid-lowering therapy (pitavastatin monotherapy) after ACS. The entire cohort was divided into three groups according to tertiles of HDL-C levels at 3-month follow-up (Group 1, HDL-C ≤43 mg/dL; Group 2, HDL-C >43, <53. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2020.05.005DOI Listing

[Algorithm to stratify the risk of myocardial infarction in patients with acute coronary syndrome at primary examination.]

Klin Lab Diagn 2020 ;65(6):111-222

I.P. Pavlov First Saint Petersburg State Medical University, 197022, Saint-Petersburg, Russian Federation.

The episode of acute coronary syndrome is most often preceded by the development of systemic and local inflammation, which plays a significant role in the pathogenesis of the disease. General clinical blood analysis, directly or indirectly reflecting systemic pathological processes in the patient's body based on quantitative and morphological assessment of blood composition, is one of the most affordable methods of laboratory diagnostics in modern public health. Taking into account the growing number of digital data obtained by diagnosticians from analytical systems, there is a growing potential for the use of machine learning methods to increase the effectiveness of provided diagnostic information in the interests of the patient. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18821/0869-2084-2020-65-6-111-222DOI Listing
January 2020

Is Cardiac Rehabilitation Equally Effective in Improving Dietary Intake in All Patients with Ischemic Heart Disease?

J Am Coll Nutr 2020 May 27:1-8. Epub 2020 May 27.

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

To investigate the association between sociodemographic characteristics and changes in dietary intake in patients with ischemic heart disease who were following a cardiac rehabilitation program. Longitudinal study among patients with first-time admission to outpatient cardiac rehabilitation after ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina pectoris or stable angina pectoris. We used a validated self-administered food frequency questionnaire to assess the dietary intake before rehabilitation, post rehabilitation and 6 months after baseline. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07315724.2020.1755910DOI Listing

[Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting].

Zhonghua Xin Xue Guan Bing Za Zhi 2020 May;48(5):367-372

Tianjin Medical University, Tianjin 300070, China.

To compare clinical efficacy of interventional treatment with graft vessel and native coronary artery for patients with late saphenous vein grafts disease(SVGD) after coronary artery bypass grafting (CABG). A total of 1 608 patients underwent CABG in Tianjin Chest from March 2014 to December 2017 were screened. During the follow-up period, 165 hospitalized patients with recurrence of angina pectoris within one year after CABG, who had at least one narrow vein graft(≥50%) confirmed by the coronary angiography were enrolled. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112148-20190827-00523DOI Listing

Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.

Chin J Integr Med 2020 May 22. Epub 2020 May 22.

Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.

Objective: To investigate the shared mechanisms of scutellarin in angina pectoris (AP) and ischemic stroke (IS) treatment.

Methods: A network pharmacology approach was used to detect the potential mechanisms of scutellarin in AP and IS treatment by target prediction, protein-protein interaction (PPI) data collection, network construction, network analysis, and enrichment analysis. Furthermore, molecular docking simulation was employed to analyze the interaction between scutellarin and core targets. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11655-020-2716-4DOI Listing

Tyrosine 135 of the β subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs.

Eur J Pharmacol 2020 May 21;881:173203. Epub 2020 May 21.

Department of Pharmacology, Toxicology and Clinical Pharmacy University of Braunschweig - Institute of Technology, Germany. Electronic address:

Soluble guanylyl cyclase (sGC), the major receptor for nitric oxide (NO), is a heterodimer consisting of two subunits, the α and the β subunit. The NO/sGC/cGMP signaling pathway is protective in different disease pathomechanisms including angina pectoris, pulmonary hypertension and fibrotic diseases. The natural ligand heme has two carboxylic acids which interact in the β heme nitric oxide oxygen binding (HNOX) domain with the amino acids of the highly conserved Y-x-S-x-R motif. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2020.173203DOI Listing

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.

Trials 2020 May 23;21(1):415. Epub 2020 May 23.

Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark.

Background: Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling patients with heart failure or reduced left ventricular ejection fraction (LVEF ≤ 40%). Accordingly, the impact of beta-blockers on mortality and morbidity following acute MI in patients without reduced LVEF or heart failure is unclear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-020-4214-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245032PMC

Prospective randomized controlled trial study of Luofengning granule in the treatment of unstable angina.

Medicine (Baltimore) 2020 May;99(20):e20025

Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing.

Introduction: Although the current western treatment plans for unstable angina (UA) has been optimized in past decades, UA still is a common phenotype of acute coronary syndrome and significantly influence the quality of life and endanger lives. In China, the clinical application of Chinese herb medicine is considered as an effective approach to treating UA and widely recognized by patients. In clinical practices, we found Luofengning granule (LFN-G) could improve clinical manifestations of patients with UA, but there is lack of rigorous proof of evidence-based medicine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000020025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254781PMC

Correlation of Serum Adipolin with Epicardial Fat Thickness and Severity of Coronary Artery Diseases in Acute Myocardial Infarction and Stable Angina Pectoris Patients.

Med Princ Pract 2020 May 21. Epub 2020 May 21.

Objective: Adipolin/C1q/TNF-related protein-12 is a family of CTRPs that is highly expressed in adipose tissue and has glucose-lowering and anti-inflammatory effects. Various risk factors have been suggested in the incidence of cardiovascular diseases such as a decrease in anti-inflammatory or an increase in inflammatory factors. The purpose of the present study was to investigate the correlation of adipolin with anthropometric, angiographic, echocardiographic, and biochemical parameters. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000508834DOI Listing

Physical Activity and the Risk for Sudden Cardiac Death in Patients With Coronary Artery Disease.

Circ Arrhythm Electrophysiol 2020 Jun 20;13(6):e007908. Epub 2020 May 20.

Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Finland.

Background: The association between leisure-time physical activity (LTPA) and the risk of sudden cardiac death (SCD) in coronary artery disease patients is not well known. We aim to assess whether there is an association between LTPA and the risk of SCD and non-SCD in patients with coronary artery disease.

Methods: Patients with angiographically verified coronary artery disease (n=1946) underwent a clinical evaluation, including filling in an LTPA questionnaire and extensive risk profiling at the baseline. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCEP.119.007908DOI Listing

Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA.

Cardiol Ther 2020 May 19. Epub 2020 May 19.

Laboratory of Biostatistics, National Medical Research Center for Preventive Medicine of the Ministry of Healthcare, Moscow, Russia.

Introduction: Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation.

Methods: ODA, a 3-month, observational, multicenter study in Russia, assessed the effectiveness and tolerability of TMZ 80 mg od in patients with stable angina and persisting symptoms, in real-life settings. The present analysis explored the effects of adding TMZ to background antianginal treatment with respect to the duration of stable angina. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40119-020-00174-7DOI Listing

Improvement in quality of life and angina pectoris: 1-year follow-up of patients with refractory angina pectoris and spinal cord stimulation.

Neth Heart J 2020 May 19. Epub 2020 May 19.

Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.

Aims: Spinal cord stimulation (SCS) is a treatment for patients with refractory angina pectoris (RAP) who remain symptomatic despite optimal medical therapy and without revascularisation options. Previous studies have shown that SCS improves the quality of life in this patient group and reduces the severity of the angina pectoris. The aim of this prospective, single-arm observational study is to show this effect in a single-centre cohort using a multidisciplinary team approach to the selection process, with a follow-up period of 1 year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12471-020-01422-0DOI Listing

Apnea Hypopnea Index is an Independent Predictor of Coronary Microcirculatory Dysfunction in Stable Angina Pectoris Patients with a Single Borderline Lesion.

Acta Cardiol Sin 2020 May;36(3):207-215

Department of Cardiology, Nanjing First Hospital, Nanjing Medical University.

Background: To investigate the effect and possible mechanism of obstructive sleep apnea hypopnea syndrome on coronary microcirculation in stable angina pectoris (SAP) patients with a single borderline lesion.

Methods: We retrospectively analyzed 102 SAP patients with a single critical lesion [fractional flow reserve > 0.80] who were divided into an abnormal microcirculatory function group [index of microcirculatory resistance (IMR) ≥ 25, n = 52] and normal microcirculatory function (NMF) group (IMR < 25, n = 50). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6515/ACS.202005_36(3).20190923ADOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220967PMC

Association Between Uric Acid and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Unstable Angina Pectoris.

Am J Med Sci 2020 Apr 10. Epub 2020 Apr 10.

Department of Geriatric Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. Electronic address:

Background: The association between uric acid and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) in patients with unstable angina pectoris (UAP) is unclear.

Methods: We recruited 260 patients with UAP admitted to the first affiliated Hospital of Guangxi Medical University from February 2018 to August 2018. According to the level of uric acid, patients were divided into 4 groups (Q1 = 48. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjms.2020.04.004DOI Listing

Systemic Cardiac Troponin T Associated With Incident Atrial Fibrillation Among Patients With Suspected Stable Angina Pectoris.

Am J Cardiol 2020 Jul 12;127:30-35. Epub 2020 Apr 12.

Department of Heart Disease, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.

Higher concentrations of cardiac troponin T are associated with coronary artery disease (CAD) and adverse cardiovascular prognosis. The relation with incident atrial fibrillation (AF) is less explored. We studied this association among 3,568 patients evaluated with coronary angiography for stable angina pectoris without previous history of AF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2020.03.036DOI Listing